Alport Syndrome: Research highlights link between genotype and treatment effectiveness

A large-scale analysis of the clinical characteristics of Alport syndrome in Japanese patients has revealed that the effectiveness of existing treatment with ACE inhibitors and/or angiotensin receptor blockers (RAS inhibitors) varies depending on the type of mutation in the syndrome’s causal gene (COL4A5). RAS inhibitors are widely administered to patients with chronic kidney diseases as they are known to preserve […]

» Read more

Researchers discover key to dialogue between brain cells to protect against stroke

Research led by Nicolas Bazan, MD, Ph.D., Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans School of Medicine, and Ludmila Belayev, MD, LSU Health New Orleans Professor of Neuroscience, Neurology and Neurosurgery, has unlocked a key fundamental mechanism in the communication between brain cells when confronted with stroke. They report that DHA not […]

» Read more

1.4 million less than projected: how coronavirus could hit Australia’s population in the next 20 years

In the early stages of COVID-19, much of the focus of demographers – who study populations—has understandably been on mortality and morbidity. But as the pandemic rolls on, attention is also now turning to the impact of COVID-19 on population size, structure and distribution. Our new modelling shows that under a worst-case scenario, Australia will be 1.4 million people—or 4% […]

» Read more
1 1,667 1,668 1,669 1,670 1,671 1,813